Press releases
- Photocure ASA - Notice of the Annual General Meeting 23 May 2024
- Photocure ASA: Annual Report 2023
- European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care
- Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
- Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting
- Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN
- Photocure ASA: Results for the fourth quarter of 2023
More ▼
Key statistics
On Friday, Photocure ASA (PHOo:STO) closed at 57.80, 20.79% above the 52 week low of 47.85 set on Jul 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 58.00 |
---|---|
High | 58.00 |
Low | 57.80 |
Bid | 53.30 |
Offer | 54.80 |
Previous close | 57.80 |
Average volume | -- |
---|---|
Shares outstanding | 27.12m |
Free float | 26.68m |
P/E (TTM) | 7,576.60 |
Market cap | 1.48bn NOK |
EPS (TTM) | 0.0072 NOK |
Data delayed at least 15 minutes, as of Mar 22 2024 17:00 BST.
More ▼